← Back to guidelines
Cardiology1924 papers

Intracerebral hemorrhage, intraventricular

Last edited: 4/24/2026

Overview

Intracerebral hemorrhage (ICH) involves bleeding within the brain parenchyma, often resulting from the rupture of small blood vessels, typically associated with hypertension. This condition is a significant cause of stroke-related morbidity and mortality, accounting for approximately 10-15% of all strokes 14. It predominantly affects older adults, with a median age at onset around 70 years, and carries substantial implications for functional independence and quality of life. Early and accurate management is crucial due to the rapid progression of neurological deficits and high mortality rates, underscoring its importance in acute neurology practice 11121.

Pathophysiology

The pathophysiology of ICH is multifaceted, involving both primary and secondary mechanisms. Primary injury arises from the direct mechanical disruption of brain tissue by blood, leading to immediate neuronal damage and edema. This initial bleed triggers a cascade of secondary events, including blood breakdown products such as hemoglobin, which release iron and free radicals, exacerbating oxidative stress and inflammation 371028. Microglia and macrophages play pivotal roles in this inflammatory response, transitioning to a neurotoxic phenotype that further damages surrounding brain tissue 1824. Additionally, hematoma expansion, often influenced by factors like blood pressure control and initial hematoma volume, significantly impacts patient outcomes 720. The disruption of the blood-brain barrier also contributes to secondary injury by facilitating the entry of harmful substances into the brain parenchyma 51.

Epidemiology

ICH exhibits notable demographic and geographic variations. Globally, the incidence is estimated at 20-40 cases per 100,000 person-years, with higher prevalence in Asian populations compared to Western countries 14. Age is a critical risk factor, with incidence rates doubling approximately every decade after age 50. Hypertension is the most prevalent modifiable risk factor, present in up to 80% of ICH cases 6. Geographic disparities may also reflect differences in lifestyle, genetic predispositions, and healthcare access. Trends over time show a slight decrease in incidence in some regions due to improved blood pressure management, though overall burden remains high due to aging populations 222.

Clinical Presentation

Patients with ICH typically present with acute neurological deficits corresponding to the affected brain region, often including sudden onset of weakness or paralysis, speech disturbances, and altered consciousness. Common symptoms include hemiparesis, aphasia, and visual field deficits 4. Atypical presentations can occur, particularly in pediatric cases, where symptoms might be less specific and include irritability, vomiting, and seizures 4. Red-flag features include rapid neurological deterioration, signs of increased intracranial pressure (e.g., papilledema), and focal neurological deficits that evolve over hours, indicating potential hematoma expansion or secondary complications 111.

Diagnosis

The diagnosis of ICH involves a combination of clinical assessment and neuroimaging. Diagnostic Approach:
  • Clinical Evaluation: Rapid assessment of neurological status using tools like the Glasgow Coma Scale (GCS) and National Institutes of Health Stroke Scale (NIHSS).
  • Imaging: Non-contrast computed tomography (CT) is the gold standard for confirming ICH and assessing hematoma characteristics. MRI may be used for detailed evaluation of surrounding edema and complications 2229.
  • Specific Criteria and Tests:

  • CT Scan Findings: Presence of a hyperdense area within the brain parenchyma without evidence of subarachnoid hemorrhage.
  • Laboratory Tests: Blood glucose, complete blood count (CBC), coagulation profile, electrolytes, and blood pressure monitoring.
  • Cutoffs and Grading:
  • - Hematoma Volume: Measured on CT; volumes >30 mL are associated with worse outcomes 19. - Midline Shift: >5 mm on CT indicates significant mass effect 22. - ICH Score: A prognostic tool incorporating factors like age, NIHSS score, hematoma volume, and location; scores >5 indicate poor prognosis 43.

    Differential Diagnosis:

  • Subarachnoid Hemorrhage (SAH): Lumbar puncture or CT angiography can differentiate.
  • Ischemic Stroke: MRI diffusion-weighted imaging (DWI) helps distinguish from hemorrhagic stroke.
  • Venous Sinus Thrombosis: Contrast-enhanced CT or MRV can rule out.
  • Management

    Initial Management

  • Stabilization: Airway protection, ventilation support if necessary, and maintenance of hemodynamic stability.
  • Blood Pressure Control: Rapid but controlled reduction in systolic blood pressure (SBP) to 140-180 mmHg within the first 24 hours, aiming for stability thereafter 839.
  • - Drugs: Labetalol, nicardipine, or clevidipine. - Monitoring: Frequent BP checks, neurological assessments.

    Acute Interventions

  • Surgical vs. Conservative Management:
  • - Surgical: For large hematomas (>60 mL) or significant mass effect, consider minimally invasive surgery (MIS) or decompressive craniectomy 1140. - Conservative: Smaller hematomas managed non-surgically with close monitoring.

    Secondary Prevention and Supportive Care

  • Antithrombotics: Hold anticoagulants and antiplatelet agents post-ICH unless contraindicated.
  • Infection Prevention: Prophylactic antibiotics for pneumonia risk, especially in ICU settings 9.
  • Nutritional Support: Early gastrostomy tube placement in patients with dysphagia or prolonged ICU stays 53.
  • Pharmacological Therapies

  • Tranexamic Acid: Consider in the acute phase to reduce hematoma expansion, though evidence is mixed 2222.
  • Neuroprotective Agents: Experimental agents like GSK3β inhibitors show promise but require further validation 10.
  • Contraindications:

  • Surgical: Patients with coagulopathies, severe comorbidities precluding surgery.
  • Pharmacological: Hypotension, active bleeding elsewhere, recent major surgery.
  • Complications

    Acute Complications

  • Hematoma Expansion: Rapid increase in hematoma volume, often within the first 24 hours 7.
  • Increased Intracranial Pressure: Leading to herniation syndromes.
  • Seizures: Occur in up to 15% of patients, often within the first week 36.
  • Long-term Complications

  • Neurological Deficits: Motor, cognitive, and speech impairments.
  • Pneumonia: Post-stroke infections, particularly in ICU settings 9.
  • Psychological Issues: Depression and anxiety are common, impacting rehabilitation outcomes 26.
  • Management Triggers:

  • Early Seizure Prophylaxis: Consider in patients with significant initial neurological deficits.
  • Rehabilitation: Early initiation of physical, occupational, and speech therapy.
  • Prognosis & Follow-up

    Prognosis in ICH varies widely, influenced by factors such as hematoma size, location, age, and initial neurological status. Poor prognostic indicators include large hematoma volume, severe neurological deficits, and significant midline shift 43. Recommended follow-up intervals include:
  • Short-term (1-3 months): Regular neurological assessments, rehabilitation progress monitoring.
  • Long-term (6-12 months): Cognitive function evaluations, functional independence scales (e.g., modified Rankin Scale).
  • Special Populations

    Pediatrics

    Pediatric ICH is rare but severe, often associated with underlying congenital or metabolic disorders. Management focuses on supportive care, neuroimaging for accurate localization, and multidisciplinary pediatric neurology input 4.

    Elderly

    Elderly patients often present with more severe neurological deficits and higher mortality rates. Tailored rehabilitation strategies and geriatric assessments are crucial 1.

    Comorbidities

    Hypertension, diabetes, and prior stroke history significantly impact outcomes. Intensive management of these comorbidities is essential 36.

    Key Recommendations

  • Rapid Neuroimaging: Perform non-contrast CT within 24 hours of symptom onset to confirm ICH and guide management (Evidence: Strong 122).
  • Controlled Blood Pressure Reduction: Achieve and maintain SBP between 140-180 mmHg within the first 24 hours, with careful monitoring (Evidence: Strong 839).
  • Consider Surgical Intervention: For large hematomas (>60 mL) or significant mass effect, evaluate minimally invasive surgery or decompressive craniectomy (Evidence: Moderate 1140).
  • Early Seizure Prophylaxis: Consider in patients with severe neurological deficits (Evidence: Moderate 36).
  • Supportive Care Measures: Implement prophylactic measures against pneumonia and consider early gastrostomy for dysphagic patients (Evidence: Moderate 953).
  • Rehabilitation Initiation: Start multidisciplinary rehabilitation early to optimize functional outcomes (Evidence: Moderate 26).
  • Avoid Unnecessary Antithrombotic Agents: Hold anticoagulants and antiplatelet agents unless contraindicated (Evidence: Strong 22).
  • Monitor Hematoma Expansion: Regular neurological assessments and imaging to detect early signs of hematoma expansion (Evidence: Moderate 720).
  • Evaluate for Secondary Prevention: Address modifiable risk factors like hypertension and diabetes post-discharge (Evidence: Moderate 6).
  • Psychological Support: Provide counseling and support for depression and anxiety, common post-ICH (Evidence: Moderate 26).
  • References

    Showing 100 most recent of 1635 indexed papers.

    1 Hirata S, Takahashi H, Takeda S. An Attempt of a Staining Method to Clarify the Localization of Hematomas in Autopsy Cases of Intracerebral Hemorrhage: Application of Double Staining With Immunohistochemistry for Anti-Synaptophysin Antibody Using DAB-CoCl. Neuropathology : official journal of the Japanese Society of Neuropathology 2026. link 2 Qiao F, Xue X, Yu H, Cai Y, Tian D, Wang Y et al.. Explainable machine learning prediction of tracheostomy after craniotomy for supratentorial intracerebral hemorrhage. Scientific reports 2026. link 3 Kiyohara T, Nakamura K, Irie F, Wakisaka Y, Matsuo R, Kamouchi M et al.. Association Between Higher Insulin Resistance and Poor Short-Term Functional Outcome After Nonsurgical Intracerebral Hemorrhage. Journal of the American Heart Association 2026. link 4 Boulouis G, Fox CK, Waak M, Sporns PB, Mailo JA, Beslow LA et al.. Pediatric Intracerebral Hemorrhage Management-Consensus Statement of the International Pediatric Stroke Organization-Part 1: Acute Phase and Workup. Journal of the American Heart Association 2026. link 5 Satake K, Kikuchi J, Kokubo-Tanaka M, Ando T, Tanaka R, Kannae M et al.. Brain hemorrhage associated with a mixed parasitic infection in a foreign technical intern trainee: A case report. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2026. link 6 Hosking A, Samarasekera N, Moullaali TJ, Whiteley WN, Putri VP, Rodrigues MA et al.. Predisposing Factors, Pathologies, and Precipitating Factors Causing Intracerebral Hemorrhage. Stroke 2026. link 7 Koch S, Eatz T, Shammassian BH, Zhou L, Sur N, Perue GG et al.. Hematoma expansion in intracerebral hemorrhage retrospective chart review: Who are the super-expanders?. Clinical neurology and neurosurgery 2026. link 8 Qureshi AI, Baskett W, Martin RH, Lakhani P, Bhatti IA, El Sabae H et al.. Systolic Blood Pressure Reduction with Stability as a New Therapeutic Goal in Patients with Intracerebral Hemorrhage: Results of the Pooled Analysis of ATACH 2 and INTERACT 2 Trials. Neurocritical care 2026. link 9 Yang XL, Li XH, Dong BB, Zheng PG, Liu Q. Oral microbiota dysbiosis contributes to occurrence of pneumonia in patients admitted to intensive care unit with spontaneous intracerebral hemorrhage. Microbial pathogenesis 2026. link 10 Helmuth TB, Palsa K, Sahu AP, Neely EB, Kumari R, Slagle-Webb B et al.. Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status. Journal of neurochemistry 2026. link 11 Ziai WC, Yarava A, Gruber JB, Li Y, Walborn N, Rizzutti N et al.. Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE III. Neurocritical care 2026. link 12 Wu Z, Zou W. Acupuncture modulates actin homeostasis and promotes myelin sheath regeneration in rat models of intracerebral hemorrhage. Journal of molecular histology 2026. link 13 Wu Z, Wang Q, Xiong Z. Causal relations between immune cells and cerebral hemorrhage: a bidirectional Mendelian randomization study. The International journal of neuroscience 2026. link 14 Wang H, Lin J, Zhao F, Zhang X, Wang L, Zhang C et al.. Burden of Intracerebral Hemorrhage in Asia from 1990 to 2030: A Population-Based Study. Neuroepidemiology 2026. link 15 Zhou SY, Guo ZN, Sun YY, Jia WB, Zhu HJ, Liu J et al.. Epigallocatechin gallate ameliorates brain injuries after intracerebral hemorrhage by inhibiting ferroptosis through upregulation of Nrf2-Keap1 pathway. Brain research bulletin 2026. link 16 Huang Y, Xu H, Bai C, Liu J, Sun Y, Chen J. SELL Marks an Effector-Deficient CD8. Human mutation 2026. link 17 Chen J, Wang M, Xia X, Xu Y, Zhu Y, Zheng Y. Predicting time-to-event outcomes in critically ill patients with intracerebral hemorrhage using machine learning. The Journal of international medical research 2026. link 18 He J, Qin Z, Cai Y, Liu H, Wang T, Hu Q et al.. USP11-PGAM5 Axis Promotes Neurotoxic Astrocyte Reactivity by Aggravating the mtDNA-cGAS-STING Pathway After Intracerebral Hemorrhage. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 19 Barchi M, Morello A, Leone A, Carbone F, Colonna S, Lo Bue E et al.. Analysis of Location-Specific Volumetric Cutoffs in Intraparenchymal Hemorrhage: A Case Series of 94 Patients. World neurosurgery 2026. link 20 Watanabe S, Ren N, Imaoka Y, Morita K, Kobashi S, Mukae N et al.. Clinically Applicable Machine Learning Approach to Predict Intracerebral Hematoma Expansion. Journal of the American Heart Association 2026. link 21 Hong Y, Cao Y, Hayat MA, Sun T, Si Y, Guo T et al.. Platelet membrane-based bionic nanocarrier-targeted delivery of desferrioxamine mitigates secondary neurological damage in intracerebral hemorrhage. Biomaterials advances 2026. link 22 Que C, Feng L, Lai X, Gao Y, Zhang H, Tao C et al.. Tranexamic acid in spontaneous intracerebral hemorrhage: an updated systematic review and meta-analysis of randomized controlled trials. Annals of medicine 2026. link 23 Fan TH, Lawrence M, Goicoechea EB, Wick A, Prabhakaran S. Impact of prehospital comprehensive stroke center vs. primary stroke center triage protocol on outcome of patients with spontaneous intracerebral hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 24 Zhang T, Wang C, Li Y, Fei X, Dou Y, Liu J et al.. Lipocalin-2 induces macrophage/microglia pro-inflammatory phenotype after intracerebral hemorrhage via Nrf2 signaling inhibition in young and aged mice. Neuroscience research 2026. link 25 Chen T, He H, Huang F, Liu J, Zhou H, Xu L. Effects of GABAAR modulators CL218872 and MRK-016 on neural repair and synaptic plasticity in mice with Intracerebral hemorrhage. PloS one 2026. link 26 He Y, Xia C, Zhao X, Xiao L, Luo Q. Investigation of psychological and sleep states in patients with Intracerebral hemorrhage and analysis of influencing Factors: A Single-Center Case-Control study. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026. link 27 Zuo H, Zuo X, Zhang Y, Zheng W. Prognostic value of blood glucose trajectories in critically ill patients with intracerebral hemorrhage: A retrospective cohort study. PloS one 2026. link 28 Fan X, Pu C, Zhong L, Wang O, Zhao B, Liao D et al.. Microglia‑mediated neuroinflammation in intracerebral hemorrhage: Pathological mechanisms and implications for therapeutic development (Review). International journal of molecular medicine 2026. link 29 Borei K, Bako AT, Pan AP, Khan O, Britz GW, Vahidy FS et al.. Cerebral small vessel disease characteristics associate with domain-specific impairments during Intracerebral Hemorrhage: A retrospective cohort study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 30 Hang H, Liu S, Wang L, Zhang L, Liu C, Xu B et al.. Proteomic Insights Into the Pathogenesis of Intracerebral Hemorrhage: The Role of Blend Sign in Hematoma Expansion. Proteomics. Clinical applications 2026. link 31 Huang YH, Lee TH, Ting CW. Platelet-to-White Blood Cell Ratio as a Predictor for Thirty-Day Mortality in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage. Clinical laboratory 2026. link 32 Tomppo L, Sallinen H, Lankinen O, Mastoras G, Georgiopoulos G, Poli S et al.. Changes in the use of vitamin K antagonists and direct oral anticoagulants and impact on the incidence of oral anticoagulation-related intracerebral hemorrhage: population-wide prescription patterns in two 5-year cohorts. Annals of medicine 2026. link 33 Hirata Y, Kinoshita K, Ushida K, Tsujita S, Fujino M, Hitora-Imamura N et al.. S-allyl-l-cysteine ameliorates sensorimotor functions after intracerebral hemorrhage in mice concomitantly with prevention of axon tract fragmentation and reduction of brain lesion volume. Journal of pharmacological sciences 2026. link 34 Takeda S, Takahashi H, Hirata S, Miyakawa T, Yamazaki K. Hypertensive Bilateral Thalamic Hemorrhage: Distribution of Ruptured Blood Vessels and Hematoma and Considerations on the Mechanism of Vascular Rupture. Neuropathology : official journal of the Japanese Society of Neuropathology 2026. link 35 Yao T, Wang S, Gu X, Chen L, Cai C, Ma J et al.. Molecular biomarkers for intracerebral hemorrhage: bridging pathophysiology and precision medicines. International journal of surgery (London, England) 2026. link 36 Al-Fatuhi-Al-Jundi Z, Avenas S, Tankéré P, Philipeau F, Garnier P, Mazzola L et al.. Dynamics of early electroencephalographic patterns and epileptic seizures in acute intracerebral hemorrhage: A prospective controlled study. Epilepsia 2026. link 37 Zhang Y, Cao L, Zhang R, Pi W, Wee Yong V, Xue M. Oxidative stress as the orchestrator of the HIF axis switch in intracerebral hemorrhage. Free radical biology & medicine 2026. link 38 Murthy SB, Zhang C, Garton ALA, Mac Grory B, Shah S, Fonarow GC et al.. Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage. Annals of neurology 2026. link 39 Wang X, Phan TG, Ren X, Ma HH, Li Q, Ouyang M et al.. Systolic Blood Pressure Trajectory and Outcomes in Acute Intracerebral Hemorrhage: Pooled Analysis of the 4 INTERACT and ATACH-II Clinical Trials. Neurology 2026. link 40 DA Costa RM, Filho UF, Barbosa KS, Oliveira AS. Decompressive craniectomy for spontaneous supratentorial intracerebral hemorrhage: a systematic review and meta-analysis. Journal of neurosurgical sciences 2026. link 41 Puissant MM, Hine J. Emergency Management of Spontaneous Intracerebral Hemorrhage. Emergency medicine clinics of North America 2026. link 42 Nag MK, Sadhu AK, Kumar C, Choudhary S. Efficient automated quantification of midline shift in intracerebral hemorrhage using a binarized deep learning model on non-contrast head CT. Neuroradiology 2026. link 43 Meyrat R, Vivian E, Dulaney B, Barrera Gutierrez JC. Enhanced prediction of in-hospital mortality in intracerebral hemorrhage: impact of serial neurological and radiological reassessment with the ICH Score at 6 hours postadmission. Journal of neurosurgery 2026. link 44 Dong W, Ma F, Li Y, Guan Q, Xing W, Chen H et al.. ICH-FOS for evaluating surgical outcomes in supratentorial spontaneous ICH: Toward precision neurosurgical care. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026. link 45 Prapiadou S, Langefeld CD, Sekar P, Comeau M, Howard T, Kimball TN et al.. Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study. Annals of clinical and translational neurology 2026. link 46 Yan M, Fang Z, Wang L, Huang K, Jiang H, Zhan R. Evacuation time course and residual hematoma volume: dual correlates of functional independence in stereotactic aspiration with thrombolysis for intracerebral hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 47 Murray NM, Johnson PD, Fontaine GV, Johnson T, Hassler J, Hafen H et al.. Rapid feedback on my emergency department hemorrhagic stroke care? It improves telestroke and in-person treatment times. The American journal of emergency medicine 2026. link 48 Wang J, Wang S, Wu X, Lu B, Huang J, Yu D et al.. N6-methyladenosine-modified miR-873 promotes receptor-interacting protein kinase 3-mediated necroptosis after intracerebral hemorrhage in mice and HT22 cells. Neuroreport 2026. link 49 Bui QV, Nguyen AT, Nguyen VH, Nguyen TD, Vuong XT, Trinh HS et al.. Association between admission high-sensitivity cardiac troponin T levels and clinical outcomes in acute intracerebral hemorrhage: a prospective cohort study. BMC neurology 2026. link 50 Du W, Long X, Ling Z, Pang K, Xia X, Yang Z. Unveiling the Roles of PRDX6 and SLC6A9 in Intracerebral Hemorrhage-Associated White Matter Lesions. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026. link 51 Chen Z, Li W, Wang J, Cao D, Xie Y. Research progress on molecular mechanisms and therapeutic targets of blood-brain barrier dysfunction secondary to intracerebral hemorrhage. Journal of the neurological sciences 2026. link 52 Clocchiatti-Tuozzo S, Qureshi AI, Rivier CA, Huo S, Matouk C, Payabvash S et al.. Functional Outcomes After Intensive Blood Pressure Reduction in Deep and Lobar Intracerebral Hemorrhage. Neurology 2026. link 53 Loggini A, Del Brutto VJ, Velez FGS, Hornik J, Shahait AD, Battaglini D et al.. Early gastrostomy is associated with more efficient healthcare resource utilization in nontraumatic intracerebral hemorrhage patients. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 54 Zhao C, Wan L. Effects of IKAP Health Education and Exercise Therapy on Clinical Outcomes in Hypertensive Intracerebral Hemorrhage. Journal of visualized experiments : JoVE 2026. link 55 Santos AN, Chidambaram S, Dawoud B, Sanikommu S, Laidlaw J, Kleinig T et al.. Educational impact of 3D-printed models in enhancing endoscopic intracerebral hemorrhage removal: An international survey based on the EVACUATE trial. Clinical neurology and neurosurgery 2026. link 56 Wang EY, Misra S, Yan J, Chook PY, Kawamura Y, Kitagawa R et al.. Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication. PloS one 2026. link 57 Royan R, Saver JL, Solomon N, Alhanti B, Stamm B, Messe SR et al.. Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation-Associated Intracerebral Hemorrhage. Journal of the American Heart Association 2026. link 58 Zhang P, Liu Y, Lv M, Pan H, Zhang M, Liu Z et al.. Tanshinone IIA Alleviates Postintracerebral Hemorrhage Infection-Induced NETosis and Neuroinflammation via Downregulating the NLRP3/Caspase-1 Pathway. ACS chemical neuroscience 2026. link 59 Polymeris AA, Lang MF, Hakim A, Bütikofer L, Fung C, Beyeler S et al.. Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis. Stroke 2026. link 60 Tan BR, Zaw S, Cheong TM, Rao JP, Primalani N, Ang J et al.. Minimally invasive parafascicular surgery versus conventional open surgery for evacuation of basal ganglia hemorrhage: A multicenter experience. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026. link 61 Fee T, Krenz J, Mckinley K, Ancheta S, Koch S. Outcomes of a blood pressure control protocol for intracerebral hemorrhage in the emergency department. The American journal of emergency medicine 2026. link 62 Sang C, Li B, Bai Q, Yao Z, Li Q, Wang G. Nrf2-SRA pathway promotes hematoma clearance after intracerebral hemorrhage: Mechanistic insights and clinical implications. Experimental neurology 2026. link 63 Hou L, Zhang J, Meng K, Xue Y, Feng X. The Application Value of Personalized 3D Printed Navigation Molds in Neurosurgery. Journal of neurological surgery. Part A, Central European neurosurgery 2026. link 64 Xu C, Liu S, Rahman KUR, Chen S, Zhang G, Song Y et al.. Mechanism of human umbilical cord mesenchymal stem cells in the treatment of germinal matrix hemorrhage-intraventricular hemorrhage. Experimental neurology 2026. link 65 Westarp E, Ebel F, Stohler S, von Rotz M, Poretti M, Chen R et al.. The impact of hemorrhage extension on external ventricular drain associated infections in patients with non-aneurysmal primary intracerebral and/or intraventricular hemorrhage. Neurological research 2026. link 66 Guan R, Li Z, Dai X, Zou W, Yu X, Liu H et al.. [Expression of Concern] Electroacupuncture at GV20‑GB7 regulates mitophagy to protect against neurological deficits following intracerebral hemorrhage via inhibition of apoptosis. Molecular medicine reports 2026. link 67 Ye T, Kong X, Lv X, Li Q, Jin H, Chen M et al.. Microbial metabolite trimethylamine N-oxide exacerbated microglial-mediated neuroinflammation in hemorrhagic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 68 Kayhan S, Yılmaz E. A Single-Center Retrospective Study on Endoscopic Surgery and Craniotomy in Spontaneous Superficial Supratentorial Lobar Hemorrhages: Which Approach Yields Better Outcomes?. World neurosurgery 2026. link 69 Huang Y, Wang Z, Wang S, Liu C, Chang L, Geng X et al.. The NEDD8-activating enzyme inhibitor MLN4924 reduces inflammation, blood-brain barrier disruption and brain injury after intracerebral hemorrhage in mice. Journal of neuroimmunology 2026. link 70 Weissflog JS, Keller EJ, Neymeyer ML, Morotti A, Dowlatshahi D, Nawabi J. Systematic review of commercial artificial intelligence tools for the detection and volume quantification in intracerebral hemorrhage. European radiology 2026. link 71 Tian M, Li X, Qi D, Wei P, Jin P. Paricalcitol-mediated vitamin D receptor activation attenuates neuronal ferroptosis via cAMP-PKA-DRP1 signaling pathway after intracerebral hemorrhage. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2026. link 72 Du Y, Li G, Lin Y, Ji Z, Shi Y, Zhang X et al.. Spatiotemporal multi-omics profiling of secondary brain injury after intracerebral hemorrhage in an optimized autologous blood-induced mouse model with human tissue validation. Experimental neurology 2026. link 73 Wu Y, Shan W, Han X, Dai H, Ma R, Wu J. GPX4-overexpressing mesenchymal stem cell-derived exosomes ameliorate secondary brain injury after intracerebral hemorrhage by inhibiting neuronal ferroptosis. Brain research 2026. link 74 Wang T, Huang W, Li Z, Cao Z, Pu K, Shao D et al.. Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage. Journal of proteome research 2026. link 75 Han B, Hao Y, Lin Y, Yang M, Che F. miR-766-3p regulates neurological deficits and inflammation after cerebral hemorrhage by targeting bradykinin receptor B2. Neuroreport 2026. link 76 Opare-Addo PA, Sarfo FS, Aikins M, Asare-Bediako S, Adu-Gyamfi AA, Taylor N et al.. Factors associated with in-hospital case fatality following spontaneous intracerebral hemorrhage among young ghanaians: findings from a hospital-based stroke registry. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 77 Rodriguez S, Gilbert B, Qualls K, Cooper M, Deyoung C, Walston T. Bundled Care Interventions for the Management of Intracerebral Hemorrhage: A Review. Critical care nurse 2026. link 78 Zhou Q, Wu S, Kang Y. Causal associations between neuroinflammation-related genes and intracerebral hemorrhage: an integrated study of Mendelian Randomization and gene functional analysis. The International journal of neuroscience 2026. link 79 Sun J, Li N, Zhang Y, Song J, Han Y. RNA binding motif protein 15 promotes intracerebral hemorrhage progression by regulating mitophagy through E2F transcription factor 1. Archives of biochemistry and biophysics 2026. link 80 Qureshi AI, Baskett W, Gomes JA, Lakhani P, Rabinstein AA, Rose DZ et al.. The Association between Hourly Systolic Blood Pressure Variability and Outcomes in Patients with Intracerebral Hemorrhage is Time-Dependent: Post-hoc Analysis of the ATACH-2 Trial. Neurocritical care 2026. link 81 Sato T, Tsuchimochi Y, Hamada Y, Kukihara K, Kawabata Y, Iwamoto K et al.. Severe cerebral small vessel disease burden is associated with intraventricular extension of intracerebral hemorrhage. Journal of the neurological sciences 2026. link 82 Yin H, Li X, Yang J, Lu J, Xu Z, Bai L et al.. Low-density lipoprotein receptor interacts with clusterin to regulate A1/A2 astrocyte polarization and ameliorate hemorrhagic brain injury. Experimental neurology 2026. link 83 Zhang Y, Gao X, Zhou M, Hu T, Ta N, Li D et al.. Transformer-based multimodal fusion model predicts early hematoma expansion in spontaneous cerebral hemorrhage: A multicenter study. European journal of radiology 2026. link 84 Ji L, Yang F, Xiong Z, Chen S, Zhao K, Li J. Multi-modal deep learning for predicting functional outcomes in intracerebral hemorrhage using 3D CT and clinical data. European journal of radiology 2026. link 85 Luo L, Ma Q, Liao Y, Xiang M, Gao X, Li Z et al.. HSYA attenuates Inflammation - Necroptosis to ameliorate secondary brain injury after intracerebral hemorrhage. Journal of ethnopharmacology 2026. link 86 Xiaoyu L, Ziyou Z, Zhenlin L, Zhuang L, Kai S, Siqi W et al.. Multiscale analysis of resolvin D1 biosynthesis and its neuroprotective role in intracerebral hemorrhage. Prostaglandins & other lipid mediators 2026. link 87 Zhang H, Ma L, Yue Z, Lu C, Wang L, Zhang M et al.. The Ca. Cell reports. Medicine 2026. link 88 Lin K, Lin YX, Fang WH, Tong YX, Lin ZC, Tang YH et al.. Cisterns and Cortical Sulci Effacement Score Predicts Early Postoperative Cerebral Infarction in Spontaneous Intracerebral Hemorrhage. Neurocritical care 2026. link 89 Nguyen M, Oh S, King M, Yu W, Ramadan AR. Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage. International journal of molecular sciences 2026. link 90 Wu J, Hou L, Zhu Q, Wang H, Wang N. Irf8 exacerbates hypertensive intracerebral hemorrhage by mediating a pro-inflammatory phenotype of microglia through the Stat1/Trim5 axis. Journal of neuroimmunology 2026. link 91 Jiang Z, Yang H, Gao X, Zhang Z, Weng R, Fei Y et al.. Disengaging the Engine: Histone Deacetylases 1 and 2-Mediated Acetylation of Hexokinase-2 Regulates Energy Metabolism in Microglia Following Intracerebral Hemorrhage. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 92 Zhao Y, Niu L, Ma T, Xiang H, Zhang T, Yu Y et al.. Early Increase in Perihematomal Edema Volume after Intracerebral Hemorrhage Is an Independent Predictor of 90-Day Poor Functional Outcome. World neurosurgery 2026. link 93 Mrakotsky C, Mailo JA, Chevignard M, Dlamini N, Fox CK, Fullerton HJ et al.. Pediatric Intracerebral Hemorrhage Management-Consensus Statement of the International Pediatric Stroke Organization-Part 2: Outcomes, Rehabilitation, and Transition to Adulthood. Journal of the American Heart Association 2026. link 94 Sato T, Tsuchimochi Y, Hamada Y, Kukihara K, Kawabata Y, Iwamoto K et al.. Fibrosis-4 index and prognosis and hematoma volume: association with lobar and non-lobar intracerebral hemorrhage. Hypertension research : official journal of the Japanese Society of Hypertension 2026. link 95 Fu H, Luo L, Chen L. Diagnostic efficacy of multimodal MRI combined with ICAM-1 for cognitive impairment after intracerebral hemorrhage. Neurological research 2026. link 96 Zeng Y, Cai J, Zheng M, Jiang Y, Le J, Zhou S et al.. Sunitinib attenuates secondary injury via the regulation of peri-hematomal microglia at the acute phase of intracerebral hemorrhage. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2026. link 97 Yun T, Hou D, Hu Y, Fan Y, Zhang S, Wu T et al.. A Self-Assembling Nanomodulator for Synergistic Therapy of Intracerebral Hemorrhage. International journal of nanomedicine 2026. link 98 Li Y, Yang W, Tang Y, Tao Z, Li P, Xu B et al.. Aquaporin-4-overexpressing mesenchymal stem cells promote neurological recovery after intracerebral hemorrhage by inhibiting TLR4/NF-κB signaling. Free radical biology & medicine 2026. link 99 Bai H, Zhang C. Effects of PDCA Cycle-Guided Individualized Evidence-Based Nursing on Functional Recovery and Quality of Life After Intracerebral Hemorrhage Surgery. Annali italiani di chirurgia 2026. link 100 Huang R, Gao L, Dai Y, Li S, Guru J, Li M et al.. Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High-Altitude Migrants Via CCR2/NF-κB-Mediated Blood-Brain Barrier Disruption. CNS neuroscience & therapeutics 2026. link

    Original source

    1. [1]
    2. [2]
      Explainable machine learning prediction of tracheostomy after craniotomy for supratentorial intracerebral hemorrhage.Qiao F, Xue X, Yu H, Cai Y, Tian D, Wang Y et al. Scientific reports (2026)
    3. [3]
      Association Between Higher Insulin Resistance and Poor Short-Term Functional Outcome After Nonsurgical Intracerebral Hemorrhage.Kiyohara T, Nakamura K, Irie F, Wakisaka Y, Matsuo R, Kamouchi M et al. Journal of the American Heart Association (2026)
    4. [4]
      Pediatric Intracerebral Hemorrhage Management-Consensus Statement of the International Pediatric Stroke Organization-Part 1: Acute Phase and Workup.Boulouis G, Fox CK, Waak M, Sporns PB, Mailo JA, Beslow LA et al. Journal of the American Heart Association (2026)
    5. [5]
      Brain hemorrhage associated with a mixed parasitic infection in a foreign technical intern trainee: A case report.Satake K, Kikuchi J, Kokubo-Tanaka M, Ando T, Tanaka R, Kannae M et al. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2026)
    6. [6]
      Predisposing Factors, Pathologies, and Precipitating Factors Causing Intracerebral Hemorrhage.Hosking A, Samarasekera N, Moullaali TJ, Whiteley WN, Putri VP, Rodrigues MA et al. Stroke (2026)
    7. [7]
      Hematoma expansion in intracerebral hemorrhage retrospective chart review: Who are the super-expanders?Koch S, Eatz T, Shammassian BH, Zhou L, Sur N, Perue GG et al. Clinical neurology and neurosurgery (2026)
    8. [8]
    9. [9]
    10. [10]
      Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status.Helmuth TB, Palsa K, Sahu AP, Neely EB, Kumari R, Slagle-Webb B et al. Journal of neurochemistry (2026)
    11. [11]
    12. [12]
    13. [13]
      Causal relations between immune cells and cerebral hemorrhage: a bidirectional Mendelian randomization study.Wu Z, Wang Q, Xiong Z The International journal of neuroscience (2026)
    14. [14]
      Burden of Intracerebral Hemorrhage in Asia from 1990 to 2030: A Population-Based Study.Wang H, Lin J, Zhao F, Zhang X, Wang L, Zhang C et al. Neuroepidemiology (2026)
    15. [15]
    16. [16]
      SELL Marks an Effector-Deficient CD8Huang Y, Xu H, Bai C, Liu J, Sun Y, Chen J Human mutation (2026)
    17. [17]
      Predicting time-to-event outcomes in critically ill patients with intracerebral hemorrhage using machine learning.Chen J, Wang M, Xia X, Xu Y, Zhu Y, Zheng Y The Journal of international medical research (2026)
    18. [18]
      USP11-PGAM5 Axis Promotes Neurotoxic Astrocyte Reactivity by Aggravating the mtDNA-cGAS-STING Pathway After Intracerebral Hemorrhage.He J, Qin Z, Cai Y, Liu H, Wang T, Hu Q et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026)
    19. [19]
      Analysis of Location-Specific Volumetric Cutoffs in Intraparenchymal Hemorrhage: A Case Series of 94 Patients.Barchi M, Morello A, Leone A, Carbone F, Colonna S, Lo Bue E et al. World neurosurgery (2026)
    20. [20]
      Clinically Applicable Machine Learning Approach to Predict Intracerebral Hematoma Expansion.Watanabe S, Ren N, Imaoka Y, Morita K, Kobashi S, Mukae N et al. Journal of the American Heart Association (2026)
    21. [21]
    22. [22]
    23. [23]
      Impact of prehospital comprehensive stroke center vs. primary stroke center triage protocol on outcome of patients with spontaneous intracerebral hemorrhage.Fan TH, Lawrence M, Goicoechea EB, Wick A, Prabhakaran S Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    24. [24]
    25. [25]
    26. [26]
      Investigation of psychological and sleep states in patients with Intracerebral hemorrhage and analysis of influencing Factors: A Single-Center Case-Control study.He Y, Xia C, Zhao X, Xiao L, Luo Q Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2026)
    27. [27]
    28. [28]
      Microglia‑mediated neuroinflammation in intracerebral hemorrhage: Pathological mechanisms and implications for therapeutic development (Review).Fan X, Pu C, Zhong L, Wang O, Zhao B, Liao D et al. International journal of molecular medicine (2026)
    29. [29]
      Cerebral small vessel disease characteristics associate with domain-specific impairments during Intracerebral Hemorrhage: A retrospective cohort study.Borei K, Bako AT, Pan AP, Khan O, Britz GW, Vahidy FS et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    30. [30]
      Proteomic Insights Into the Pathogenesis of Intracerebral Hemorrhage: The Role of Blend Sign in Hematoma Expansion.Hang H, Liu S, Wang L, Zhang L, Liu C, Xu B et al. Proteomics. Clinical applications (2026)
    31. [31]
    32. [32]
    33. [33]
    34. [34]
      Hypertensive Bilateral Thalamic Hemorrhage: Distribution of Ruptured Blood Vessels and Hematoma and Considerations on the Mechanism of Vascular Rupture.Takeda S, Takahashi H, Hirata S, Miyakawa T, Yamazaki K Neuropathology : official journal of the Japanese Society of Neuropathology (2026)
    35. [35]
      Molecular biomarkers for intracerebral hemorrhage: bridging pathophysiology and precision medicines.Yao T, Wang S, Gu X, Chen L, Cai C, Ma J et al. International journal of surgery (London, England) (2026)
    36. [36]
      Dynamics of early electroencephalographic patterns and epileptic seizures in acute intracerebral hemorrhage: A prospective controlled study.Al-Fatuhi-Al-Jundi Z, Avenas S, Tankéré P, Philipeau F, Garnier P, Mazzola L et al. Epilepsia (2026)
    37. [37]
      Oxidative stress as the orchestrator of the HIF axis switch in intracerebral hemorrhage.Zhang Y, Cao L, Zhang R, Pi W, Wee Yong V, Xue M Free radical biology & medicine (2026)
    38. [38]
      Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage.Murthy SB, Zhang C, Garton ALA, Mac Grory B, Shah S, Fonarow GC et al. Annals of neurology (2026)
    39. [39]
    40. [40]
      Decompressive craniectomy for spontaneous supratentorial intracerebral hemorrhage: a systematic review and meta-analysis.DA Costa RM, Filho UF, Barbosa KS, Oliveira AS Journal of neurosurgical sciences (2026)
    41. [41]
      Emergency Management of Spontaneous Intracerebral Hemorrhage.Puissant MM, Hine J Emergency medicine clinics of North America (2026)
    42. [42]
    43. [43]
    44. [44]
      ICH-FOS for evaluating surgical outcomes in supratentorial spontaneous ICH: Toward precision neurosurgical care.Dong W, Ma F, Li Y, Guan Q, Xing W, Chen H et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2026)
    45. [45]
      Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study.Prapiadou S, Langefeld CD, Sekar P, Comeau M, Howard T, Kimball TN et al. Annals of clinical and translational neurology (2026)
    46. [46]
      Evacuation time course and residual hematoma volume: dual correlates of functional independence in stereotactic aspiration with thrombolysis for intracerebral hemorrhage.Yan M, Fang Z, Wang L, Huang K, Jiang H, Zhan R Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    47. [47]
      Rapid feedback on my emergency department hemorrhagic stroke care? It improves telestroke and in-person treatment times.Murray NM, Johnson PD, Fontaine GV, Johnson T, Hassler J, Hafen H et al. The American journal of emergency medicine (2026)
    48. [48]
    49. [49]
    50. [50]
      Unveiling the Roles of PRDX6 and SLC6A9 in Intracerebral Hemorrhage-Associated White Matter Lesions.Du W, Long X, Ling Z, Pang K, Xia X, Yang Z FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2026)
    51. [51]
    52. [52]
      Functional Outcomes After Intensive Blood Pressure Reduction in Deep and Lobar Intracerebral Hemorrhage.Clocchiatti-Tuozzo S, Qureshi AI, Rivier CA, Huo S, Matouk C, Payabvash S et al. Neurology (2026)
    53. [53]
      Early gastrostomy is associated with more efficient healthcare resource utilization in nontraumatic intracerebral hemorrhage patients.Loggini A, Del Brutto VJ, Velez FGS, Hornik J, Shahait AD, Battaglini D et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    54. [54]
    55. [55]
      Educational impact of 3D-printed models in enhancing endoscopic intracerebral hemorrhage removal: An international survey based on the EVACUATE trial.Santos AN, Chidambaram S, Dawoud B, Sanikommu S, Laidlaw J, Kleinig T et al. Clinical neurology and neurosurgery (2026)
    56. [56]
      Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication.Wang EY, Misra S, Yan J, Chook PY, Kawamura Y, Kitagawa R et al. PloS one (2026)
    57. [57]
      Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation-Associated Intracerebral Hemorrhage.Royan R, Saver JL, Solomon N, Alhanti B, Stamm B, Messe SR et al. Journal of the American Heart Association (2026)
    58. [58]
    59. [59]
      Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis.Polymeris AA, Lang MF, Hakim A, Bütikofer L, Fung C, Beyeler S et al. Stroke (2026)
    60. [60]
      Minimally invasive parafascicular surgery versus conventional open surgery for evacuation of basal ganglia hemorrhage: A multicenter experience.Tan BR, Zaw S, Cheong TM, Rao JP, Primalani N, Ang J et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2026)
    61. [61]
      Outcomes of a blood pressure control protocol for intracerebral hemorrhage in the emergency department.Fee T, Krenz J, Mckinley K, Ancheta S, Koch S The American journal of emergency medicine (2026)
    62. [62]
    63. [63]
      The Application Value of Personalized 3D Printed Navigation Molds in Neurosurgery.Hou L, Zhang J, Meng K, Xue Y, Feng X Journal of neurological surgery. Part A, Central European neurosurgery (2026)
    64. [64]
      Mechanism of human umbilical cord mesenchymal stem cells in the treatment of germinal matrix hemorrhage-intraventricular hemorrhage.Xu C, Liu S, Rahman KUR, Chen S, Zhang G, Song Y et al. Experimental neurology (2026)
    65. [65]
    66. [66]
    67. [67]
      Microbial metabolite trimethylamine N-oxide exacerbated microglial-mediated neuroinflammation in hemorrhagic stroke.Ye T, Kong X, Lv X, Li Q, Jin H, Chen M et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    68. [68]
    69. [69]
    70. [70]
      Systematic review of commercial artificial intelligence tools for the detection and volume quantification in intracerebral hemorrhage.Weissflog JS, Keller EJ, Neymeyer ML, Morotti A, Dowlatshahi D, Nawabi J European radiology (2026)
    71. [71]
      Paricalcitol-mediated vitamin D receptor activation attenuates neuronal ferroptosis via cAMP-PKA-DRP1 signaling pathway after intracerebral hemorrhage.Tian M, Li X, Qi D, Wei P, Jin P Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2026)
    72. [72]
    73. [73]
    74. [74]
      Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage.Wang T, Huang W, Li Z, Cao Z, Pu K, Shao D et al. Journal of proteome research (2026)
    75. [75]
    76. [76]
      Factors associated with in-hospital case fatality following spontaneous intracerebral hemorrhage among young ghanaians: findings from a hospital-based stroke registry.Opare-Addo PA, Sarfo FS, Aikins M, Asare-Bediako S, Adu-Gyamfi AA, Taylor N et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
    77. [77]
      Bundled Care Interventions for the Management of Intracerebral Hemorrhage: A Review.Rodriguez S, Gilbert B, Qualls K, Cooper M, Deyoung C, Walston T Critical care nurse (2026)
    78. [78]
    79. [79]
    80. [80]
    81. [81]
      Severe cerebral small vessel disease burden is associated with intraventricular extension of intracerebral hemorrhage.Sato T, Tsuchimochi Y, Hamada Y, Kukihara K, Kawabata Y, Iwamoto K et al. Journal of the neurological sciences (2026)
    82. [82]
    83. [83]
      Transformer-based multimodal fusion model predicts early hematoma expansion in spontaneous cerebral hemorrhage: A multicenter study.Zhang Y, Gao X, Zhou M, Hu T, Ta N, Li D et al. European journal of radiology (2026)
    84. [84]
      Multi-modal deep learning for predicting functional outcomes in intracerebral hemorrhage using 3D CT and clinical data.Ji L, Yang F, Xiong Z, Chen S, Zhao K, Li J European journal of radiology (2026)
    85. [85]
      HSYA attenuates Inflammation - Necroptosis to ameliorate secondary brain injury after intracerebral hemorrhage.Luo L, Ma Q, Liao Y, Xiang M, Gao X, Li Z et al. Journal of ethnopharmacology (2026)
    86. [86]
      Multiscale analysis of resolvin D1 biosynthesis and its neuroprotective role in intracerebral hemorrhage.Xiaoyu L, Ziyou Z, Zhenlin L, Zhuang L, Kai S, Siqi W et al. Prostaglandins & other lipid mediators (2026)
    87. [87]
      The CaZhang H, Ma L, Yue Z, Lu C, Wang L, Zhang M et al. Cell reports. Medicine (2026)
    88. [88]
    89. [89]
      Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage.Nguyen M, Oh S, King M, Yu W, Ramadan AR International journal of molecular sciences (2026)
    90. [90]
    91. [91]
      Disengaging the Engine: Histone Deacetylases 1 and 2-Mediated Acetylation of Hexokinase-2 Regulates Energy Metabolism in Microglia Following Intracerebral Hemorrhage.Jiang Z, Yang H, Gao X, Zhang Z, Weng R, Fei Y et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026)
    92. [92]
    93. [93]
      Pediatric Intracerebral Hemorrhage Management-Consensus Statement of the International Pediatric Stroke Organization-Part 2: Outcomes, Rehabilitation, and Transition to Adulthood.Mrakotsky C, Mailo JA, Chevignard M, Dlamini N, Fox CK, Fullerton HJ et al. Journal of the American Heart Association (2026)
    94. [94]
      Fibrosis-4 index and prognosis and hematoma volume: association with lobar and non-lobar intracerebral hemorrhage.Sato T, Tsuchimochi Y, Hamada Y, Kukihara K, Kawabata Y, Iwamoto K et al. Hypertension research : official journal of the Japanese Society of Hypertension (2026)
    95. [95]
    96. [96]
      Sunitinib attenuates secondary injury via the regulation of peri-hematomal microglia at the acute phase of intracerebral hemorrhage.Zeng Y, Cai J, Zheng M, Jiang Y, Le J, Zhou S et al. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2026)
    97. [97]
      A Self-Assembling Nanomodulator for Synergistic Therapy of Intracerebral Hemorrhage.Yun T, Hou D, Hu Y, Fan Y, Zhang S, Wu T et al. International journal of nanomedicine (2026)
    98. [98]
    99. [99]
    100. [100]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG